Cypress Growth Capital

About The Fund

Cypress Growth Capital is a Dallas-based Venture Capital Fund specialized in royalty-based growth capital investments, primarily targeting businesses within the Software, IT and TMT, Business Solutions, FinTech and Financial services, Medical Devices and Hospital Services, and Healthcare and Wellness industries. Founded in 2010, Cypress Growth Capital positions itself as the largest and most experienced royalty-based growth capital investor in the United States, providing non-dilutive growth funding alternatives to traditional equity and debt instruments. By offering capital in exchange for a fixed percentage of a company's future monthly revenues, they enable entrepreneurs to obtain necessary funding without sacrificing equity or company control. Their financial arrangements are praised for their simplicity and flexibility, adapting to a company's revenue performance. Cypress Growth Capital actively avoids taking a board seat or imposing other control provisions commonly associated with equity investments. Their investment portfolio highlights a track record of significant growth and achievement of desired outcomes, such as follow-on growth equity rounds, majority recapitalizations, or strategic sales. As a firm with $100 million in assets under management, Cypress Growth Capital offers investments ranging from $1 million to $5 million, specifically designed for emerging companies seeking to preserve equity and maintain control during expansion. The team at Cypress, equipped with operational and entrepreneurial experience, also provides strategic guidance to assist the growth and scaling of businesses beyond the provision of capital.